资讯
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Dailymotion on MSN6 小时
Ugandans hopeful for access to HIV injection drug, LenacapavirAlthough Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...
The FDA approval of lenacapavir as a form of preexposure prophylaxis (PrEP) is a major step for HIV prevention, but its ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...
Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...
6 天
AllAfrica on MSNKenya to Roll Out Long-Acting Injectable HIV Prep Lenacapavir By Jan 2026Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
The Global Fund has secured access to lenacapavir, a groundbreaking HIV prevention drug, for low and middle-income countries, ...
7 天
TheHealthSite on MSNWhat Is Lenacapavir? All About WHO Recommended Biannual HIV Prevention DrugA breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果